Connecting the dots linking mind, behavior, and disease: The biological concomitants of coping patterns: Commentary on "Attachment and cancer: A conceptual integration"

Integrative Cancer Therapies

Volumn 1, Issue 4, 2002, Pages 387-391

  Temoshok, Lydia R ^a  

^a INSTITUTE OF HUMAN VIROLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTATION; ADAPTIVE BEHAVIOR; BEHAVIOR; COGNITION; COPING BEHAVIOR; ELECTRODERMAL RESPONSE; EMOTION; EMOTIONAL ATTACHMENT; HUMAN; NEOPLASM; NOTE; OBJECT RELATION; PATHOPHYSIOLOGY; PERSONALITY; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; PSYCHOTHERAPY; SOCIAL PSYCHOLOGY;

ADAPTATION, PHYSIOLOGICAL; ADAPTATION, PSYCHOLOGICAL; HUMANS; NEOPLASMS; OBJECT ATTACHMENT; PSYCHOTHERAPY;

EID: 0042695574     PISSN: 15347354     EISSN: None     Source Type: Journal    
DOI: 10.1177/1534735402238189     Document Type: Note

References (27)

1. Temoshok L. Personality, coping style, emotion, and cancer: toward an integrative model. Cancer Surveys. 1987;6:545-567.
2. Greer S, Morris T, Pettingale KW. Psychological response to breast cancer: effect on outcome. Lancet. 1979;2:785-787.
3. Watson M, Haviland JS, Greer S, Davidson J, Bliss JM. Influence of psychological response on survival in breast cancer: a population cohort study. Lancet. 1999;354:1331-1336.
4. Temoshok L, Heller BW, Sagebiel RW, et al. The relationship of psychosocial factors to prognostic indicators in cutaneous malignant melanoma. J Psychosom Res. 1985;29:139-153.
5. Temoshok L. Biopsychosocial studies on cutaneous malignant melanoma: psychological factors associated with prognostic indicators, progression, psychophysiology, and tumor-host response. Soc Sci Med. 1985;20:833-840.
6. Solano L, Costa M, Temoshok L, et al. An emotionally inexpressive (type C) coping style influences HIV disease progression at six and twelve month follow-ups. Psychol Health. 2002;17:641-655.
7. Fawzi FI, Fawzy NW, Hyun CS, et al. Malignant melanoma: effects of an early structured psychiatric intervention, coping, and affective state on recurrence and survival 6 years later. Arch Gen Psychiatry. 1993;50:681-689.
8. Temoshok L. Emotion, adaptation, and disease: a multidimensional model. In: Temoshok L, Van Dyke C, Zegans LS, eds. Emotions in Health and Illness: Theoretical and Research Foundations. New York, NY: Grune & Stratton Inc; 1983:207-233.
9. Ekman P. Asymmetry in facial expression. Science. 1980;204:832-834.
10. Lazarus RS. Stress and emotion: a new synthesis. NY: Springer Publishing, 1999.
11. Tulving E. Episodic memory: from mind to brain. Ann Rev Psychol. 2002;53:1-25.
12. Phillips RG, LeDoux JE. Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning. Behav Neurosci. 1992;106:274-285.
13. Tomkins SS. Script theory: differential magnification of affects. In: Dienstbier RA, ed. Human Emotion: Nebraska Symposium on Motivation 1978. Lincoln: University of Nebraska Press; 1979:201-236.
14. Kneier AW, Temoshok L. Repressive coping reactions in patients with malignant melanoma as compared to cardiovascular disease patients. J Psychosom Res. 1984;29:139-153.
15. Temoshok L. On attempting to articulate the biopsychosocial model: psychological-psychophysiological homeostasis. In: Friedman H, ed. Personality and Disease. New York, NY: John Wiley & Sons; 1990:203-225.
16. Temoshok LR. The complexity of cause: linking emotional dynamics to health outcomes. In: Vingerhoets A, van Bussel F, Boelhouwer J, eds. The (Non) Expression of Emotions in Health and Disease. Tilburg, the Netherlands: Tilburg University Press; 1997:181-192.
17. Temoshok, L. Complex coping patterns and their role in adaptation and neuroimmunomodulation: theory, methodology, and research. Ann N Y Acad Sci. 2000;917:446-455.
18. Glaser R, Rabin B, Chesney M, Cohen S, Natelson B. Stress-induced immunomodulation: implications for infectious diseases? JAMA. 1999;28:2268-2270.
19. Herberman RB. Principles of tumor immunology. In: Holleb AI, Fink DJ, Murphy GP, eds. American Cancer Society Textbook of Clinical Oncology, Atlanta, Ga: American Cancer Society; 1991:69-79.
20. Cocci F, DeVico A, Carzino-Demo A, Cara A, Gallo R, Lusso P. The V3 domain of the HIV-1 gp120 envelope glycoprotein is critical for chemokine-mediated blockade of infection. Nat Med. 1996;2:1244-1247.
21. McEwen BS, Stellar E. Stress and the individual: mechanisms leading to disease. Arch Intern Med. 1993;153:2093-2101.
22. McEwen BS. Protective and damaging effects of stress mediators. N Engl J Med. 1998;338:171-179.
23. Sterling P, Eyer J. Allostasis: a new paradigm to explain arousal pathology. In: Fisher S, Reason J, eds. Handbook of Life Stress, Cognition and Health. New York, NY: John Wiley; 1988:629-649.
24. McEwen BS, Seeman T. Protective and damaging effects of mediators of stress: elaborating and testing the concepts of allostasis and allostatic load. Ann N Y Acad Sci. 1999;896:30-47.
25. Cohen S, Doyle WJ, Skoner DP, Rabin BS, Gwaltney JM Jr. Social ties and susceptibility to the common cold. JAMA. 1997;277:1940-1944.
26. Hadid R, Spinedi E, Giovambattista A, Chautard T, Gaillard RC. Decreased hypothalamo-pituitary-adrenal axis response to neuroendocrine challenge under repeated endotoxemia. Neuroimmunomodulation. 1996;3:62-68.
27. Meaney MJ, Tannenbaum B, Francis D, et al. Early environmental programming: hypothalamic-pituitary-adrenal responses to stress. Semin Neurosci. 1994;6:247-259.